Analyst Ratings For Abbott Laboratories (NYSE:ABT)
Today, Royal Bank Of Canada reiterated its Buy rating on Abbott Laboratories (NYSE:ABT) with a price target of $55.00.
There are 4 hold ratings, 8 buy ratings on the stock.
The current consensus rating on Abbott Laboratories (NYSE:ABT) is Buy (Score: 2.67) with a consensus target price of $54.75 per share, a potential 1.86% upside.
Some recent analyst ratings include
- 10/3/2017-Royal Bank Of Canada Reiterated Rating of Buy.
- 10/2/2017-BMO Capital Markets Reiterated Rating of Hold.
- 9/24/2017-Cowen and Company Reiterated Rating of Buy.
- 8/17/2017-Citigroup Inc. initiated coverage with a Neutral rating.
- 8/3/2017-Jefferies Group LLC Reiterated Rating of Buy.
Dividend information for Abbott Laboratories (NYSE:ABT)
Abbott Laboratories (NYSE:ABT) pays an annual dividend of Community Ranking: with a yield of 1.97% and an average dividend growth of 22.90% based on a 3 Year Average.
Dividend History for Abbott Laboratories (NYSE:ABT)
- On 9/15/2017 Abbott Laboratories announced a quarterly dividend of $0.27 2.05% with an ex dividend date of 10/12/2017 which will be payable on 11/15/2017.
- On 6/9/2017 Abbott Laboratories announced a quarterly dividend of $0.27 2.25% with an ex dividend date of 7/12/2017 which will be payable on 8/15/2017.
- On 2/17/2017 Abbott Laboratories announced a quarterly dividend of $0.27 2.36% with an ex dividend date of 4/11/2017 which will be payable on 5/15/2017.
- On 12/9/2016 Abbott Laboratories announced a quarterly dividend of $0.27 2.7% with an ex dividend date of 1/11/2017 which will be payable on 2/15/2017.
- On 9/15/2016 Abbott Laboratories announced a quarterly dividend of $0.26 2.48% with an ex dividend date of 10/12/2016 which will be payable on 11/15/2016.
- On 6/10/2016 Abbott Laboratories announced a quarterly dividend of $0.26 2.75% with an ex dividend date of 7/13/2016 which will be payable on 8/15/2016.
- On 2/19/2016 Abbott Laboratories announced a quarterly dividend of $0.26 2.66% with an ex dividend date of 4/13/2016 which will be payable on 5/16/2016.
Recent Insider Trading Activity For Abbott Laboratories (NYSE:ABT)
Abbott Laboratories (NYSE:ABT) has insider ownership of 0.76% and institutional ownership of 71.50%.
- On 9/26/2017 Daniel Gesua Sive Salvadori, Insider, sold 62,460 with an average share price of $52.95 per share and the total transaction amounting to $3,307,257.00. View SEC Filing
- On 9/22/2017 Jaime Contreras, Insider, sold 52,700 with an average share price of $51.97 per share and the total transaction amounting to $2,738,819.00. View SEC Filing
- On 8/16/2017 Stephen R Fussell, Insider, sold 196,550 with an average share price of $49.50 per share and the total transaction amounting to $9,729,225.00. View SEC Filing
- On 8/1/2017 Sharon J Bracken, Insider, sold 2,000 with an average share price of $49.16 per share and the total transaction amounting to $98,320.00. View SEC Filing
- On 7/27/2017 Brian J Blaser, Insider, sold 15,000 with an average share price of $50.00 per share and the total transaction amounting to $750,000.00. View SEC Filing
- On 7/25/2017 Hubert L Allen, Insider, sold 4,600 with an average share price of $50.79 per share and the total transaction amounting to $233,634.00. View SEC Filing
- On 6/15/2017 Jared Watkin, Insider, sold 552 with an average share price of $47.97 per share and the total transaction amounting to $26,479.44. View SEC Filing
Recent Trading Activity for Abbott Laboratories (NYSE:ABT)
Shares of Abbott Laboratories closed the previous trading session at with shares trading hands.